Expert Meetings

6th Closed Scientific Expert Meeting of the Editorial Board

Amsterdam, The Netherlands, 24th August, 2023 (Educational supporters)

CVD and omega-3 fatty acids: Is arterial inflammation the key?

CVD risk reduction in HIV infection: The REPRIEVE Trial

Insights into apoC3’s mechanism of action

5th Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 19th April, 2023 (Educational supporters)

ANGPTL8: The third musketeer?

Fibrates: Finished or still fighting?

Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1

4th Closed Scientific Expert Meeting of the Editorial Board

Barcelona, Spain, 26th August, 2022 (Educational supporters)

ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease

ANGPTL3/8 inhibition: Clinical results

ApoCIII inhibition: Impact of TG lowering

3rd Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 13th April, 2022 (Educational supporters)

ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins?

Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years?

Novel PPAR agonists as therapeutics in hypertriglyceridaemia

2nd Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 18th October, 2021 (Educational supporters)

Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle

Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis

Keynote – Pancreatitis: Genetic complexity

1st Closed Scientific Expert Meeting of the Editorial Board

Virtual meeting, 20th May, 2021 (Educational supporters)

Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk

Keynote – Atherogenic potential of postprandial lipaemia in diabetes

Keynote – Relevance of TRL and remnants in FH

Reportage from major congresses will feature here

One of our most popular articles would feature here

CVD and omega-3 fatty acids: Is arterial inflammation the key?

CVD risk reduction in HIV infection: The REPRIEVE Trial

Insights into apoC3’s mechanism of action

ANGPTL8: The third musketeer?

Fibrates: Finished or still fighting?

Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1

ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease

ANGPTL3/8 inhibition: Clinical results

ApoCIII inhibition: Impact of TG lowering

ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins?

Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years?

Novel PPAR agonists as therapeutics in hypertriglyceridaemia

Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle

Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis

Keynote – Pancreatitis: Genetic complexity

Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk

Keynote – Atherogenic potential of postprandial lipaemia in diabetes

Keynote – Relevance of TRL and remnants in FH

6th Closed Scientific Expert Meeting of the Editorial Board

CVD and omega-3 fatty acids: Is arterial inflammation the key?

CVD risk reduction in HIV infection: The REPRIEVE Trial

Insights into apoC3’s mechanism of action

5th Closed Scientific Expert Meeting of the Editorial Board

ANGPTL8: The third musketeer?

Fibrates: Finished or still fighting?

Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1

4th Closed Scientific Expert Meeting of the Editorial Board

ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease

ANGPTL3/8 inhibition: Clinical results

ApoCIII inhibition: Impact of TG lowering

3rd Closed Scientific Expert Meeting of the Editorial Board

ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins?

Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years?

Novel PPAR agonists as therapeutics in hypertriglyceridaemia

2nd Closed Scientific Expert Meeting of the Editorial Board

Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle

Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis

Keynote – Pancreatitis: Genetic complexity

1st Closed Scientific Expert Meeting of the Editorial Board

Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk

Keynote – Atherogenic potential of postprandial lipaemia in diabetes

Keynote – Relevance of TRL and remnants in FH

Educational partners and supporters